Ruffo Frank
Insider CIK 1654450 · ACRS Chief Financial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ACRS Aclaris Therapeutics, Inc. | S Sale | 2022-03-10 | 2022-03-14 | 12,823 | $15.55 | $199.4K | 201,883 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2022-03-02 | 2022-03-03 | 8,297 | — | $0 | 16,595 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2022-03-02 | 2022-03-03 | 8,297 | — | $0 | 214,706 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2022-03-01 | 2022-03-03 | 8,300 | — | $0 | 24,900 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2022-03-01 | 2022-03-03 | 25,750 | — | $0 | 25,750 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2022-03-01 | 2022-03-03 | 44,300 | — | $0 | 44,300 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2022-03-01 | 2022-03-03 | 155,200 | — | $0 | 155,200 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2022-03-01 | 2022-03-03 | 8,300 | — | $0 | 206,409 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2022-03-01 | 2022-03-03 | 25,750 | — | $0 | 198,109 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | S Sale | 2022-02-09 | 2022-02-11 | 1,388 | $12.66 | $17.6K | 172,359 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2022-02-01 | 2022-02-03 | 3,875 | — | $0 | 0 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2022-02-01 | 2022-02-03 | 3,875 | — | $0 | 173,747 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | S Sale | 2021-06-02 | 2021-06-02 | 12,587 | $21.51 | $270.7K | 172,322 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | S Sale | 2021-06-02 | 2021-06-02 | 2,450 | $22.30 | $54.6K | 169,872 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2021-06-01 | 2021-06-02 | 33,189 | — | $0 | 0 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2021-06-01 | 2021-06-02 | 33,189 | — | $0 | 184,909 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | S Sale | 2021-04-26 | 2021-04-26 | 27,239 | $25.79 | $702.5K | 151,820 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | S Sale | 2021-04-26 | 2021-04-26 | 100 | $26.44 | $2.6K | 151,720 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | S Sale | 2021-04-23 | 2021-04-26 | 29,200 | $26.64 | $777.9K | 179,859 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | S Sale | 2021-04-23 | 2021-04-26 | 800 | $27.33 | $21.9K | 179,059 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | S Sale | 2021-04-22 | 2021-04-26 | 30,000 | $26.84 | $805.2K | 209,059 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2021-03-02 | 2021-03-03 | 8,297 | — | $0 | 24,892 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | F Tax w/h | 2021-03-02 | 2021-03-03 | 2,844 | $23.25 | $66.1K | 239,059 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2021-03-02 | 2021-03-03 | 8,297 | — | $0 | 241,903 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2021-03-01 | 2021-03-03 | 116,000 | — | $0 | 116,000 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2021-03-01 | 2021-03-03 | 33,200 | — | $0 | 33,200 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2021-03-01 | 2021-03-03 | 25,750 | — | $0 | 51,500 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2021-03-01 | 2021-03-03 | 25,750 | — | $0 | 240,939 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | F Tax w/h | 2021-03-01 | 2021-03-03 | 7,333 | $24.06 | $176.4K | 233,606 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2021-02-01 | 2021-02-03 | 3,875 | — | $0 | 3,875 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | F Tax w/h | 2021-02-01 | 2021-02-03 | 1,308 | $21.35 | $27.9K | 215,189 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2021-02-01 | 2021-02-03 | 3,875 | — | $0 | 216,497 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2020-12-15 | 2020-12-17 | 1,300 | — | $0 | 0 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2020-12-15 | 2020-12-17 | 1,300 | — | $0 | 212,992 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | F Tax w/h | 2020-12-15 | 2020-12-17 | 370 | $4.59 | $1.7K | 212,622 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2020-06-01 | 2020-06-03 | 33,188 | — | $0 | 33,189 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2020-06-01 | 2020-06-03 | 33,188 | — | $0 | 221,143 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | F Tax w/h | 2020-06-01 | 2020-06-03 | 9,451 | $1.32 | $12.5K | 211,692 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2020-03-02 | 2020-03-04 | 25,750 | — | $0 | 77,250 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2020-03-02 | 2020-03-04 | 33,189 | — | $0 | 33,189 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2020-03-02 | 2020-03-04 | 66,377 | — | $0 | 66,377 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2020-03-02 | 2020-03-04 | 116,160 | — | $0 | 116,160 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | F Tax w/h | 2020-03-02 | 2020-03-04 | 7,162 | $1.26 | $9.0K | 187,955 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2020-03-02 | 2020-03-04 | 25,750 | — | $0 | 195,117 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2020-02-03 | 2020-02-04 | 3,875 | — | $0 | 7,750 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | F Tax w/h | 2020-02-03 | 2020-02-04 | 1,308 | $1.28 | $1.7K | 169,367 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2020-02-03 | 2020-02-04 | 3,875 | — | $0 | 170,675 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2019-12-18 | 2019-12-20 | 1,250 | — | $0 | 0 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | F Tax w/h | 2019-12-18 | 2019-12-20 | 356 | $1.81 | $644 | 166,800 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2019-12-18 | 2019-12-20 | 1,250 | — | $0 | 167,156 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2019-12-16 | 2019-12-18 | 1,300 | — | $0 | 1,300 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | F Tax w/h | 2019-12-16 | 2019-12-18 | 370 | $1.80 | $666 | 165,906 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2019-12-16 | 2019-12-18 | 1,300 | — | $0 | 166,276 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2019-03-01 | 2019-03-04 | 103,000 | — | $0 | 103,000 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2019-02-01 | 2019-02-05 | 3,875 | — | $0 | 11,625 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | F Tax w/h | 2019-02-01 | 2019-02-05 | 1,308 | $6.96 | $9.1K | 164,976 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2019-02-01 | 2019-02-05 | 3,875 | — | $0 | 166,284 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2018-12-18 | 2018-12-21 | 1,250 | — | $0 | 1,250 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2018-12-18 | 2018-12-21 | 1,250 | — | $0 | 162,765 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | F Tax w/h | 2018-12-18 | 2018-12-21 | 356 | $6.30 | $2.2K | 162,409 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2018-12-15 | 2018-12-18 | 1,300 | — | $0 | 2,600 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | F Tax w/h | 2018-12-15 | 2018-12-18 | 370 | $7.31 | $2.7K | 161,515 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2018-12-15 | 2018-12-18 | 1,300 | — | $0 | 161,885 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2018-05-07 | 2018-05-09 | 5,200 | — | $0 | 3,900 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | P Buy | 2018-05-07 | 2018-05-07 | 1,250 | $18.22 | $22.8K | 156,865 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | F Tax w/h | 2018-05-07 | 2018-05-09 | 1,480 | $18.10 | $26.8K | 160,585 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2018-05-07 | 2018-05-09 | 5,200 | — | $0 | 162,065 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | P Buy | 2018-04-06 | 2018-04-09 | 1,250 | $16.59 | $20.7K | 155,615 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | J Other | 2018-03-16 | 2018-03-20 | 9,018 | — | $0 | 154,365 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2018-02-01 | 2018-02-05 | 15,500 | — | $0 | 15,500 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2018-02-01 | 2018-02-05 | 54,000 | — | $0 | 54,000 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2017-12-18 | 2017-12-21 | 1,250 | — | $0 | 2,500 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2017-12-18 | 2017-12-21 | 1,250 | — | $0 | 145,727 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | F Tax w/h | 2017-12-18 | 2017-12-21 | 380 | $24.12 | $9.2K | 145,347 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2017-12-15 | 2017-12-21 | 1,300 | — | $0 | 9,100 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | F Tax w/h | 2017-12-15 | 2017-12-21 | 395 | $24.23 | $9.6K | 144,477 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2017-12-15 | 2017-12-21 | 1,300 | — | $0 | 144,872 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2016-12-18 | 2016-12-20 | 1,250 | — | $0 | 3,750 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | F Tax w/h | 2016-12-18 | 2016-12-20 | 380 | $31.25 | $11.9K | 143,572 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2016-12-18 | 2016-12-20 | 1,250 | — | $0 | 143,952 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2016-12-15 | 2016-12-19 | 10,400 | — | $0 | 10,400 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2016-12-15 | 2016-12-19 | 62,400 | — | $0 | 62,400 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | J Other | 2016-09-15 | 2016-09-19 | 4,790 | — | $0 | 142,702 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2015-12-18 | 2015-12-22 | 5,000 | — | $0 | 5,000 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2015-12-18 | 2015-12-22 | 49,439 | — | $0 | 49,439 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | C Conversion deriv | 2015-10-13 | 2015-10-13 | 5,802 | — | $0 | 0 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | C Conversion deriv | 2015-10-13 | 2015-10-13 | 20,000 | — | $0 | 0 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | C Conversion | 2015-10-13 | 2015-10-13 | 7,478 | — | $0 | 137,912 | SEC↗ |